Lipoprotein(a) in the cerebrospinal fluid of neurological patients with blood-cerebrospinal fluid barrier dysfunction

Clinical Chemistry

Volumn 52, Issue 11, 2006, Pages 2043-2048

  Pepe, Gabriella ^a,b   Chimienti, Guglielmina ^a   Liuzzi, Grazia Maria ^a   Lamanuzzi, Biagia Leila ^a   Nardulli, Marina ^a   Lolli, Francesco ^c   Anglés Cano, Eduardo ^d   Matà, Sabrina ^c  

^a UNIVERSITY OF BARI   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER DYSFUNCTION; CEREBROSPINAL FLUID ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PREDICTION; SERUM; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BLOOD-BRAIN BARRIER; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PREDICTIVE VALUE OF TESTS; PROTEIN ISOFORMS;

EID: 33750479039     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.073544     Document Type: Article

References (25)

1. Roheim PS, Carey M, Forte T, Vega GL. Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci U S A 1979;76:4646-9.
2. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH. Lipoproteins and their receptors in the central nervous system: characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain. J Biol Chem 1987;262:14352-60.
3. Danik M, Champagne D, Petit-Turcotte C, Beffert U, Poirier J. Brain lipoprotein metabolism and its relation to neurodegenerative disease. Crit Rev Neurobiol 1999;13:357-407.
4. Bassett CN, Montine K, Neely MD, Swift L, Montine T. Cerebrospinal fluid lipoproteins in Alzheimer's disease. Microsc Res Tech 2000;50:282-6.
5. Borghini I, Barja F, Pometta D, James RW. Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim Biophys Acta 1995;1255:192-200.
6. Koch S, Donarski N, Goetze K, Kreckel M, Stuerenburg HJ, Buhmann C, et al. Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res 2001;42:1143-51.
7. Carlsson J, Armstrong VW, Reiber H, Felgenhauer K, Seidel D. Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin Chim Acta 1991;196:167-76.
8. Shie FS, Neely MD, Maezawa I, Wu H, Olson SJ, Jurgens G, et al. Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretion. Am J Pathol 2004;164:1173-81.
9. Utermann G. Lipoprotein(a). In: Scriver CR, Beaudet AL, Sly WS, Stambury JB., Wyngaarden JB., Fredrickson DS, eds. The Metabolic and Molecular Bases of Inherited Diseases. New York; McGraw-Hill, Inc. 1995:1887-912.
10. de la Pena-Diaz A, Izaguirre-Avila R, Anglés-Cano E. Lipoprotein Lp(a) and atherothrombotic disease. Arch Med Res 2000;31:353-9.
11. Chimienti G, Lamanuzzi BL, Nardulli M, Colacicco AM, La Gioia R, Scrutionio D, et al. Apo (a) variants and lipoprotein(a) in men with or without myocardial infarction. Exp Mol Pathol 2002;73:28-34.
12. Kang C, Durlach V, Soulat T, Fournier C, Anglés-Cano E. Lipoprotein(a) isoforms display differences in affinity for plasminogen-like binding to human mononuclear cells. Arterioscler Thromb Vasc Biol 1997;17:2036-43.
13. Lamanuzzi BL, Mtairag EM, Pepe G, Anglés-Cano E. Neutrophils stimulated by apolipoprotein (a) generate fragments that are stronger inhibitors of plasmin formation than apo (a). Thromb Haemost 2004;92:1066-75.
14. Tibbling G, Link H, Ohman S. Principles of albumin and IgG analyses in neurological disorders: I, Establishment of reference value. Scand J Clin Lab Invest 1977;37:385-90.
15. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders (DMS-IV), 4th ed. Washington, DC: American Psychiatric Association, 1994.
16. Brettschneider J, Claus A, Kassubeck J, Tumani H. Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases. J Neurol 2005;252:1067-73.
17. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987;300:132-7.
18. Anglés-Cano E, Loyau S, Cardoso-Saldana G, Courdec R, Gillery P. A novel kringle-4 number-based recombinant apo(a) standard for human apo(a) phenotyping. J Lipid Res 1999;40:354-9.
19. Krafl HG, Windegger M, Menzel HJ, Utermann G. Significant impact of the +93 C/T polymorphism in the apolipoprotein(a) gene on Lp(a) concentrations in Africans, but not in Caucasians: confounding effect of linkage disequilibrium. Hum Mol Genet 1998;7:257-64.
20. Nakajima K, Yamashita T, Kusuhara M, Yonemura A, Ito T, Higashi K, et al. The susceptibility of lipoprotein(a) to copper oxidation is correlated with the susceptibility of autologous low density lipoprotein to oxidation. Clin Biochem 2003;36:113-20.
21. Ren S, Man RY, Angel A, Shen GX. Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor 1 in cultured vascular endothelial cells. Atherosclerosis 1997;128:1-10.
22. Romero FI, Khamashta MA, Hughes GR. Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis. Lupus 2000;9:206-9.
23. Reiber H, Otto M, Trendelemburg C, Wormek A. Reporting cerebrospinal fluid data: knowledge base and interpretation software. Clin Chem Lab Med 2001;39:324-32.
24. Marz W, Beckmann A, Scharnagl H, Siekmeier R, Mondorf U, Held I, et al. Heterogeneous lipoprotein(a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor-related protein/α 2-macroglobulin receptor. FEBS letters 1993;325:271-5.
25. Niemeier A, Willnow T, Dieplinger H, Jacobsen C, Meyer N, Hilpert J, et al. Identification of megalin/gp330 as a receptor for lipoprotein (a) in vitro. Arterioscler Thromb Vasc Biol 1999;19:552-61.